Cozad Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,521
| Closed | -$150K | – | 415 |
|
|
2024
Q3 | $150K | Buy |
10,521
+341
| +3% | +$4.85K | 0.01% | 402 |
|
|
2024
Q2 | $132K | Hold |
10,180
| – | – | 0.01% | 394 |
|
|
2024
Q1 | $141K | Sell |
10,180
-2,382
| -19% | -$33.1K | 0.01% | 389 |
|
|
2023
Q4 | $179K | Hold |
12,562
| – | – | 0.02% | 375 |
|
|
2023
Q3 | $194K | Sell |
12,562
-309
| -2% | -$4.78K | 0.03% | 364 |
|
|
2023
Q2 | $202K | Hold |
12,871
| – | – | 0.03% | 362 |
|
|
2023
Q1 | $212K | Hold |
12,871
| – | – | 0.03% | 351 |
|
|
2022
Q4 | $201K | Hold |
12,871
| – | – | 0.03% | 360 |
|
|
2022
Q3 | $167K | Buy |
+12,871
| New | +$167K | 0.03% | 340 |
|
|
2020
Q3 | – | Sell |
-10,156
| Closed | -$182K | – | 332 |
|
|
2020
Q2 | $182K | Buy |
+10,156
| New | +$182K | 0.04% | 316 |
|